STAAR Surgical Company (STAA)

STAAR Surgical Company Cash Flow Statement

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 2, 2026	Dec 27, 2024	Dec 29, 2023	Dec 30, 2022	Dec 31, 2021
Net Income	-80.45	-20.21	21.35	39.67	27.51
Depreciation & Amortization	8.73	6.89	5.12	4.51	3.64
Stock-Based Compensation	30.59	27.21	23.52	20.37	14.61
Other Adjustments	23.23	10.19	8.7	0.05	0.6
Change in Receivables	27.83	16.49	-32.76	-19.6	-8.87
Changes in Inventories	-16.98	-10	-14.36	-7.94	0.07
Changes in Accounts Payable	-5.51	0.08	-0.7	1.81	0.11
Changes in Accrued Expenses	-4.56	-0.17	7.14	-0.59	7.01
Changes in Other Operating Activities	-17.12	-15.36	-3.41	-2.55	-0.71
Operating Cash Flow	-34.23	15.73	14.59	35.72	43.96
Operating Cash Flow Growth	-	7.75%	-59.14%	-18.76%	109.83%
Capital Expenditures	-5.82	-23.39	-18.19	-18.11	-13.65
Purchases of Investments	-75.36	-80.24	-52.31	-155.75	-
Proceeds from Sale of Investments	127.52	44.42	144.85	17.48	-
Investing Cash Flow	46.34	-59.22	74.35	-156.38	-13.65
Short-Term Debt Repaid	-	-	-	-	-1.3
Net Short-Term Debt Issued (Repaid)	-	-	-	-	-1.3
Long-Term Debt Repaid	-0.04	-0.17	-0.16	-0.13	-0.35
Net Long-Term Debt Issued (Repaid)	-0.04	-0.17	-0.16	-0.13	-0.35
Issuance of Common Stock	3.47	7.39	9.67	8.42	19.44
Repurchase of Common Stock	-7.98	-1.51	-2.1	-	-
Net Common Stock Issued (Repurchased)	-4.51	5.89	7.58	8.42	19.44
Financing Cash Flow	-4.56	5.72	7.42	8.3	17.79
Effect of Exchange Rate Changes on Cash and Cash Equivalents	1.44	-1.11	0.2	-0.86	-0.86
Net Cash Flow	8.99	-38.88	96.56	-113.23	47.25
Free Cash Flow	-40.05	-7.67	-3.59	17.61	30.32
Free Cash Flow Growth	-	-	-	-41.92%	141.63%
FCF Margin	-16.73%	-2.44%	-1.11%	6.19%	13.15%
Free Cash Flow Per Share	-0.81	-0.16	-0.07	0.36	0.61
Levered Free Cash Flow	-121.74	-62.33	-3.21	16.66	22.34
Unlevered Free Cash Flow	-130.94	-70.11	-6.6	15.26	25.77

Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q